Alan J Yaghoubian, Sarah Razavi, Kavita Gupta, Raymond Khargi, Anna Ricapito, Christopher Connors, Roman Shimonov, Dara Lundon, Blair Gallante, Kyra Gassmann, Johnathan A Khusid, William Atallah, Mantu Gupta
{"title":"Patients Who Catastrophize Pain Experience Increased Pain after Ureteroscopic Laser Lithotripsy with Stent Placement.","authors":"Alan J Yaghoubian, Sarah Razavi, Kavita Gupta, Raymond Khargi, Anna Ricapito, Christopher Connors, Roman Shimonov, Dara Lundon, Blair Gallante, Kyra Gassmann, Johnathan A Khusid, William Atallah, Mantu Gupta","doi":"10.1089/end.2024.0688","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Purpose:</i></b> Pain after ureteroscopic laser lithotripsy with stent placement (URSLL+stent) varies widely between patients. Although stent-specific factors are known to influence symptoms, patient-specific factors remain elusive. The pain catastrophizing scale (PCS) is a validated questionnaire quantifying the degree to which an individual catastrophizes painful stimuli. This study aimed to determine whether PCS score is associated with pain after URSLL+stent. <b><i>Materials and Methods:</i></b> We performed a prospective study of patients undergoing URSLL+stent. Patients completed the PCS preoperatively and were labeled as catastrophizers (CAT), noncatastrophizers (NON), or intermediate catastrophizers (INT). Primary outcome was visual analog scale (VAS) pain score, and secondary outcomes included ureteral stent symptom questionnaire scores, total analgesic pills taken, pain-related health care encounters, and need for opioids. <b><i>Results:</i></b> In total, 100 patients were enrolled, with 94 patients included in the final analysis. Median VAS in postanesthesia care unit was significantly higher for CAT and INT than NON (5.00 <i>vs</i> 5.00 <i>vs</i> 2.00, respectively, <i>p</i> = 0.042). Median VAS on postoperative day (POD)#1 was significantly higher for CAT than INT or NON (5.42 <i>vs</i> 3.0 <i>vs</i> 3.0, <i>p</i> = 0.018), but this difference disappeared by POD#10. CAT used more total tablets of prescribed medications (24.0 <i>vs</i> 15 <i>vs</i> 15 for CAT, INT, and NON, respectively, <i>p</i> = 0.002) and were more likely to require additional prescriptions, including opioids (22.6% <i>vs</i> 12.9% <i>vs</i> 0% for CAT, INT, and NON, respectively, <i>p</i> = 0.008). CAT also generated more unplanned health care encounters (25.8% <i>vs</i> 16.1% <i>vs</i> 3.1% for CAT, INT, and NON, respectively, <i>p</i> = 0.024). <b><i>Conclusion:</i></b> The PCS is a simple, rapid, and cost-free tool that allows urologists to identify patients at risk of poor pain tolerance after URSLL+stent. Further studies are necessary to determine what interventions would best serve patients who catastrophize their pain.</p>","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":" ","pages":"532-541"},"PeriodicalIF":2.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of endourology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/end.2024.0688","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Pain after ureteroscopic laser lithotripsy with stent placement (URSLL+stent) varies widely between patients. Although stent-specific factors are known to influence symptoms, patient-specific factors remain elusive. The pain catastrophizing scale (PCS) is a validated questionnaire quantifying the degree to which an individual catastrophizes painful stimuli. This study aimed to determine whether PCS score is associated with pain after URSLL+stent. Materials and Methods: We performed a prospective study of patients undergoing URSLL+stent. Patients completed the PCS preoperatively and were labeled as catastrophizers (CAT), noncatastrophizers (NON), or intermediate catastrophizers (INT). Primary outcome was visual analog scale (VAS) pain score, and secondary outcomes included ureteral stent symptom questionnaire scores, total analgesic pills taken, pain-related health care encounters, and need for opioids. Results: In total, 100 patients were enrolled, with 94 patients included in the final analysis. Median VAS in postanesthesia care unit was significantly higher for CAT and INT than NON (5.00 vs 5.00 vs 2.00, respectively, p = 0.042). Median VAS on postoperative day (POD)#1 was significantly higher for CAT than INT or NON (5.42 vs 3.0 vs 3.0, p = 0.018), but this difference disappeared by POD#10. CAT used more total tablets of prescribed medications (24.0 vs 15 vs 15 for CAT, INT, and NON, respectively, p = 0.002) and were more likely to require additional prescriptions, including opioids (22.6% vs 12.9% vs 0% for CAT, INT, and NON, respectively, p = 0.008). CAT also generated more unplanned health care encounters (25.8% vs 16.1% vs 3.1% for CAT, INT, and NON, respectively, p = 0.024). Conclusion: The PCS is a simple, rapid, and cost-free tool that allows urologists to identify patients at risk of poor pain tolerance after URSLL+stent. Further studies are necessary to determine what interventions would best serve patients who catastrophize their pain.
目的:输尿管镜激光碎石伴支架置入(URSLL+支架)后患者的疼痛差异很大。虽然已知支架特异性因素会影响症状,但患者特异性因素仍然难以捉摸。疼痛灾难化量表(PCS)是一种有效的问卷,用于量化个体对疼痛刺激灾难化的程度。本研究旨在确定PCS评分是否与URSLL+支架术后疼痛相关。材料和方法:我们对接受URSLL+支架的患者进行了一项前瞻性研究。患者术前完成PCS,并被标记为灾变者(CAT)、非灾变者(NON)或中度灾变者(INT)。主要结局是视觉模拟量表(VAS)疼痛评分,次要结局包括输尿管支架症状问卷评分、服用的镇痛药总量、与疼痛相关的医疗护理经历和阿片类药物的需求。结果:共纳入100例患者,最终纳入94例患者。麻醉后护理单元CAT和INT的VAS中位数显著高于NON(分别为5.00 vs 5.00 vs 2.00, p = 0.042)。CAT组术后第1天(POD)中位VAS评分显著高于INT组或NON组(5.42 vs 3.0 vs 3.0, p = 0.018),但到POD#10时,这一差异消失。CAT使用了更多的处方药总片剂(CAT、INT和NON分别为24.0 vs 15 vs 15, p = 0.002),并且更可能需要额外的处方,包括阿片类药物(CAT、INT和NON分别为22.6% vs 12.9% vs 0%, p = 0.008)。CAT还产生了更多的计划外医疗接触(CAT、INT和NON分别为25.8% vs 16.1% vs 3.1%, p = 0.024)。结论:PCS是一种简单、快速、免费的工具,可让泌尿科医生识别URSLL+支架后疼痛耐受不良风险的患者。进一步的研究是必要的,以确定什么样的干预措施将最好地服务于那些灾难性的疼痛患者。
期刊介绍:
Journal of Endourology, JE Case Reports, and Videourology are the leading peer-reviewed journal, case reports publication, and innovative videojournal companion covering all aspects of minimally invasive urology research, applications, and clinical outcomes.
The leading journal of minimally invasive urology for over 30 years, Journal of Endourology is the essential publication for practicing surgeons who want to keep up with the latest surgical technologies in endoscopic, laparoscopic, robotic, and image-guided procedures as they apply to benign and malignant diseases of the genitourinary tract. This flagship journal includes the companion videojournal Videourology™ with every subscription. While Journal of Endourology remains focused on publishing rigorously peer reviewed articles, Videourology accepts original videos containing material that has not been reported elsewhere, except in the form of an abstract or a conference presentation.
Journal of Endourology coverage includes:
The latest laparoscopic, robotic, endoscopic, and image-guided techniques for treating both benign and malignant conditions
Pioneering research articles
Controversial cases in endourology
Techniques in endourology with accompanying videos
Reviews and epochs in endourology
Endourology survey section of endourology relevant manuscripts published in other journals.